U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Animal & Veterinary
  3. Compliance & Enforcement
  4. CVM Untitled Letters
  1. Compliance & Enforcement

CVM Untitled Letters

Company Name Subject Date of Action Issuing Office Product Addressee Location
Boehringer Ingelheim Animal Health USA Inc. Promotional Claims 2/8/2024 CVM Polyflex (ampicillin for injectable solution)  GA
ADM Animal Nutrition Current Good Manufacturing Practice 6/11/2019 ORA Medicated Feed IL
Zoetis, Inc. Misbranding 5/24/2018 CVM Apoquel (oclacitinib tablet) IN
Elanco Animal Health Promotional Claims 5/2/2018 CVM Galliprant (grapiprant tablets) IN
Pathogenes, Inc. Unapproved Animal Drugs 8/15/2017 CVM Orogin tablet, NeuroQuel tablet, Deocoquinate Pellet FL
Zoetis, Inc. and Orion Corporation Promotional Claims 10/28/2016 CVM Sileo (dexmedetomidine oromucosal gel) MI and Finland
Elanco Animal Health, Inc. Promotional Claims 10/22/2015 CVM Pulmotil AC (tilmicosin phosphate) IN
Merck Animal Health Promotional Claims 3/10/2014 CVM Zuprevo (tildipirosin) NJ
Zoetis Inc. Promotional Claims 11/20/2023 CVM Librela (bedinvetmab injection) MI

Archived Untitled Letters

Back to Top